Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Intangibles (2016 - 2026)

Sanofi's Intangibles history spans 18 years, with the latest figure at $80.9 billion for Q1 2026.

  • On a quarterly basis, Intangibles rose 20.5% to $80.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $80.9 billion, a 20.5% increase, with the full-year FY2025 number at $78.6 billion, up 225.23% from a year prior.
  • Intangibles hit $80.9 billion in Q1 2026 for Sanofi, up from $78.6 billion in the prior quarter.
  • Over the last five years, Intangibles for SNY hit a ceiling of $80.9 billion in Q1 2026 and a floor of $22.1 billion in Q4 2022.
  • Historically, Intangibles has averaged $54.2 billion across 5 years, with a median of $67.1 billion in 2025.
  • Biggest five-year swings in Intangibles: fell 9.84% in 2022 and later surged 225.23% in 2025.
  • Tracing SNY's Intangibles over 5 years: stood at $22.1 billion in 2022, then rose by 18.51% to $26.2 billion in 2023, then dropped by 7.58% to $24.2 billion in 2024, then surged by 225.23% to $78.6 billion in 2025, then grew by 2.85% to $80.9 billion in 2026.
  • Business Quant data shows Intangibles for SNY at $80.9 billion in Q1 2026, $78.6 billion in Q4 2025, and $80.5 billion in Q3 2025.